These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14615377)

  • 1. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells.
    Müller MR; Tsakou G; Grünebach F; Schmidt SM; Brossart P
    Blood; 2004 Mar; 103(5):1763-9. PubMed ID: 14615377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate.
    Suresh K; Fraser G; Scheid E; Leber B; Gauldie J; Foley R
    Leuk Lymphoma; 2006 Feb; 47(2):297-306. PubMed ID: 16321861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
    Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
    Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
    Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
    Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy.
    de Rijke B; Fredrix H; Zoetbrood A; Scherpen F; Witteveen H; de Witte T; van de Wiel-Van Kemenade E; Dolstra H
    Blood; 2003 Oct; 102(8):2885-91. PubMed ID: 12842998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro.
    Chen J; Li HY; Wang D; Zhao JJ; Guo XZ
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1509-18. PubMed ID: 21950745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.
    Kokhaei P; Choudhury A; Mahdian R; Lundin J; Moshfegh A; Osterborg A; Mellstedt H
    Leukemia; 2004 Nov; 18(11):1810-5. PubMed ID: 15385926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
    Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
    Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
    Schmidt SM; Schag K; Müller MR; Weck MM; Appel S; Kanz L; Grünebach F; Brossart P
    Blood; 2003 Jul; 102(2):571-6. PubMed ID: 12576330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.
    Schag K; Schmidt SM; Müller MR; Weinschenk T; Appel S; Weck MM; Grünebach F; Stevanovic S; Rammensee HG; Brossart P
    Clin Cancer Res; 2004 Jun; 10(11):3658-66. PubMed ID: 15173072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats.
    Yu Z; Sun H; Zhang T; Yang T; Long H; Ma B
    Cancer Biol Ther; 2009 May; 8(10):973-80. PubMed ID: 19287216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
    Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
    Grube M; Rezvani K; Wiestner A; Fujiwara H; Sconocchia G; Melenhorst JJ; Hensel N; Marti GE; Kwak LW; Wilson W; Barrett JA
    Clin Cancer Res; 2004 Feb; 10(3):1047-56. PubMed ID: 14871984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
    Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P
    Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
    Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
    Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.